Advertisement

Menopausal Transition Linked to Adverse Changes in Lipoprotein Profile

0

Women experienced greater change in low-density lipoprotein particles from DHS-I to II, with greatest change for premenopausal, perimenopausal women

High, Long-Term Consumption of Caffeine May Pose Cardiovascular Risk

0

Impaired recovery of heart rate and blood pressure following physical exertion seen in healthy adults

Factory Noise Tied to Higher Blood Pressure in Workers

0

Higher odds seen for long-term exposure to high decibels

TV Viewing Habits in Young Adulthood Tied to Cardiovascular Disease

0

Additionally, annual increases in television viewing across midlife also tied to new coronary heart disease

Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug Use

0

Benefits include increased rates of return of spontaneous circulation

Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis

0

In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis

People With Chronic Liver Disease Face More Barriers to Health Care

0

Findings tied to higher prevalence of socioeconomic vulnerabilities compared with those with chronic obstructive pulmonary disease or cardiovascular disease

Automated Pipeline Can ID Clinically Significant Mitral Regurgitation

0

MR moderate or greater in severity and severe MR detected with high areas under the curve

Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure

0

MACE, heart failure composite end point, cardiovascular death, and all-cause death all improved with semaglutide for patients with versus without heart failure

Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price

0
By Ernie Mundell HealthDay Reporter TUESDAY, Aug. 27, 2024 (HealthDay News) -- Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says...